Watts Water Technologies, Inc. Named One of the 'World's Greenest Companies 2025' by Newsweek
To compile the list, which recognizes 750 of the most environmentally conscious and sustainable companies across 26 countries, Newsweek and its partners evaluated over 8,000 publicly listed companies. As a baseline, companies had to meet the European Union's sustainability standard, in addition to having publicly available sustainability disclosures and over 1,000 employees. Each company was scored using over 25 parameters based on greenhouse gas emissions, water usage, waste generation, and their sustainability data disclosure and commitments.
'As a leading provider of technologies and solutions designed to promote water safety, energy efficiency and water conservation around the world, this recognition demonstrates that our actions have a ripple effect,' said Robert J. Pagano, Jr., CEO, President and Chairperson of the Board. 'We are honored to once again be acknowledged by Newsweek, first as one of America's Greenest Companies for the past two years and now on a global scale. We look forward to continuing our work to combat climate change and preserve our most precious natural resource – water – for years to come.'
To learn more about Watts' Environmental, Social and Governance (ESG) efforts, read the company's 2023 Sustainability Report and visit https://www.watts.com/our-story/sustainability.
Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Jim Cramer on Eli Lilly Stock: 'It Just Got Pole-Axed, Laid to Waste'
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer commented on. Cramer highlighted the reasons behind the stock's decline recently. He remarked: 'Last and least, I look at the drug stocks and I can't believe how awful they really are, with now Eli Lilly last joining the ugly fray with its less than impactful, less thought weight loss, the pill. The Street was hoping that Lilly would be able to replace its onerous GLP-1 injection with a simple pill that would produce an equal amount of weight loss. No such luck. The stock, it just got pole-axed, laid to waste.' Pixabay/Public Domain Eli Lilly and Company (NYSE:LLY) develops and markets pharmaceuticals for diabetes, obesity, cancer, autoimmune conditions, neurological disorders, and other diseases. The company's portfolio includes treatments across multiple therapeutic areas. In a July episode, Cramer mentioned the company and said: 'What I'm thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might be a short-term peak in the use of these drugs (GLP-1s). The Achilles heel of these drugs is that they're too effective. At some point, you lose enough weight, and you might think you can stop taking them… Whatever the case, if Eli Lilly is going to break out from this level, it needs breakthroughs in new areas, heart, brain, that it just doesn't have right now, or there has to be some new data that shows something else positive that the GLP-1 drugs can do. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
34 minutes ago
- Business Wire
IMMUNOVANT INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--The law firm of Kahn Swick & Foti, LLC ('KSF') has commenced an investigation into Immunovant, Inc. (NasdaqGS: IMVT) ('Immunovant'). KSF is investigating whether Immunovant's officers and/or directors breached their fiduciary duties or otherwise violated state or federal laws. If you hold shares of Immunovant, Inc. (NasdaqGS: IMVT), we urge you to contact KSF to discuss your legal rights, without obligation or cost to you, by calling KSF toll-free at 1-833-938-0905, or by e-mailing KSF Managing Partner, Lewis Kahn, ( or visit to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit
Bloomberg
34 minutes ago
- Bloomberg
CK Hutchison Investors Eye Port Sale Update Ahead of Earnings
The next leg of CK Hutchison Holdings Ltd. 's stock rally will depend in large part on any update the conglomerate may provide on its politically sensitive global port asset sale. Shares of Hong Kong tycoon Li Ka-shing's firm have soared about 35% since an April low. The rally followed a roller-coaster ride after it first announced in March a deal to sell the assets to a consortium led by BlackRock Inc. The transaction, which includes a controlling stake in Panama ports, has since then stalled after Beijing viewed it as a threat to its interests.
